News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

News|Articles|December 25, 2023

Poetry for Inclusion 2023

Author(s)Frank A. Clark, MD

Here are some highlights from Frank A. Clark, MD’s, Poetry for Inclusion from throughout 2023, as seen in Psychiatric Times.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

rain on roof

Lighthead’s Guide to the Galaxy

ByRichard M. Berlin, MD

February 6th 2026

sad earth

"Postscript"

ByRichard M. Berlin, MD

January 30th 2026

older couple

Insensible Losses

ByRichard M. Berlin, MD

January 23rd 2026

suicide

"The New Suicide Barrier"

ByRichard M. Berlin, MD

January 16th 2026

parking garage

The New Suicide Barrier

ByRichard M. Berlin, MD

January 13th 2026

Latest CME

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

OCD, Psychedelics, and Cannabinoids: New Evidence

Glutamate and GABA: The Yin and Yang of the Human Brain

From Practice to Purpose: Cultivating Leadership in Psychiatry

Lisdexamfetamine Dimesylate Oral Solution for ADHD to Be Available Mid-2026

Buntanetap for Neurodegenerative Diseases: Positive Recommendation From Data and Safety Monitoring Board